Molecular Medicine

Langreth, Robert
September 2005
Forbes Asia;9/19/2005, Vol. 1 Issue 2, p64
The article focuses on the use of nanotechnology in medical imaging systems to detect molecular defects that indicate whether an abnormal lump is cancerous or benign. Magnetic resonance imaging and computed tomography are unable to reveal invisible workings at a molecular and cellular level. General Electric and Siemens are testing positron emission tomography agents that can detect plaque buildup. There is a need for the U.S. Food and Drug Administration to adopt a less-costly approval process for new agents.


Related Articles

  • False-negative Bone Scan and Choline PET/CT Study in a Case of Prostate Cancer: The Pitfall of the Small Cell Prostate Carcinoma Variant. Al-Tamimi, Ammad; Tan, Andrew Eik Hock; Kwong, Sidney Yu Wing; Sam, Christopher Cheng Wai; Chong, Angela; Cher Heng Tan // World Journal of Nuclear Medicine;May2012, Vol. 11 Issue 2, p75 

    We present a rare variant of prostate carcinoma. The patient is a 45-year-old male with elevated prostate-specific antigen levels at screening. Magnetic resonance imaging revealed hyperenhancing lesions throughout the axial skeleton. The fluorine-18 fluorocholine (FCH) positron emission...

  • PET/MRI: a new technology in the field of molecular imaging. Afaq, Asim; Syed, Rizwan; Bomanji, Jamshed // British Medical Bulletin;Dec2013, Vol. 108 Issue 1, p159 

    Background The introduction of the new simultaneous PET/MRI scanner opens new opportunities in functional imaging. Sources of data This article is based on the literature review and our personal experience of the first simultaneous PET/MRI scanner in the UK. Areas of agreement PET/CT is well...

  • Scans. Farndon, John // Human Body;2003, p60 

    Diagnostic imaging means using all kinds of complex machinery to make pictures or images of the body to help diagnose and understand a problem. Many imaging techniques are called scans, because they involve scanning a beam around the patient, in waves. There are many types of scans namely...

  • Merging MRI with PET Siemens challenged to prove clinical case. BROSKY, JOHN // Medical Device Daily;3/11/2011, Vol. 15 Issue 48, p1 

    The article reports on the move of Siemens to join positron emission tomography (PET) with magnetic resonance imaging (MRI) for simultaneous acquisition. It states that the clinical value of PET has been proven in computed tomography with 3.2 million examinations ordered up in 2009. According to...

  • The Myth of Multimodality Diagnostic Agents. Frangioni, John V. // Molecular Imaging;Mar/Apr2011, Vol. 10 Issue 2, p79 

    No abstract available.

  • Molecular imaging in radiology: the latest fad or the new frontier? Krestin, Gabriel P.; Bernsen, Monique R. // European Radiology;Nov2006, Vol. 16 Issue 11, p2383 

    The article reflects the revolution kickstarted by molecular imaging as a vital diagnostic tool in modern medicine. Molecular imaging is widely applied both in basic research and in clinical settings which include the mapping of the entire human genome, tools for the genetic manipulation of...

  • Stellenwert der PET/CT zur Bildgebung des kolorektalen Karzinoms. Meinel, F.G.; Schramm, N.; Haug, A.R.; Graser, A.; Reiser, M.F.; Rist, C. // Der Radiologe;Jun2012, Vol. 52 Issue 6, p529 

    Clinical/methodical issue: Fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) has emerged as a very useful imaging modality in the management of colorectal carcinoma. Data from the literature regarding the role of PET/CT in the initial diagnosis, staging,...

  • Tomography Stages Tumors More Accurately Than Magnetic Resonance Imaging. Hogle, William P. // Clinical Journal of Oncology Nursing;Jun2004, Vol. 8 Issue 3, p240 

    The article highlights a study on the comparison between the accuracy of whole-body positron emission tomography and computed tomography (PET/CT) and magnetic resonance imaging (MRI) for tumor staging. PET/CT correctly determined the primary tumor, regional lymph nodes, and distant metastasis...

  • Morphological and functional imaging studies on the diagnosis and progression of Parkinson’s disease. Brooks, D. J. // Journal of Neurology;Apr2000 Supplement 2, Vol. 247, pII11 

    This paper reviews the relative abilities of magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission tomography (SPECT), and proton magnetic resonance spectroscopy (MRS) to detect Parkinson’s disease and monitor its progression. Currently, the main...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics